AR229931A1 - Procedimiento para producir interferon de fibroblasto humano esencialmente purificado como proteina homogenea - Google Patents
Procedimiento para producir interferon de fibroblasto humano esencialmente purificado como proteina homogeneaInfo
- Publication number
- AR229931A1 AR229931A1 AR282016A AR28201680A AR229931A1 AR 229931 A1 AR229931 A1 AR 229931A1 AR 282016 A AR282016 A AR 282016A AR 28201680 A AR28201680 A AR 28201680A AR 229931 A1 AR229931 A1 AR 229931A1
- Authority
- AR
- Argentina
- Prior art keywords
- procedure
- purified human
- human fibroblast
- produce interferon
- essentially purified
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/565—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6237179A | 1979-07-31 | 1979-07-31 | |
| US13063580A | 1980-03-14 | 1980-03-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR229931A1 true AR229931A1 (es) | 1984-01-31 |
Family
ID=26742182
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AR282016A AR229931A1 (es) | 1979-07-31 | 1980-07-31 | Procedimiento para producir interferon de fibroblasto humano esencialmente purificado como proteina homogenea |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US5015730A (es) |
| JP (1) | JPH02138226A (es) |
| AR (1) | AR229931A1 (es) |
| AT (1) | AT372387B (es) |
| AU (1) | AU536274B2 (es) |
| CA (1) | CA1146468A (es) |
| CH (1) | CH648331A5 (es) |
| DE (1) | DE3028919A1 (es) |
| DK (1) | DK159825C (es) |
| DO (1) | DOP1980002948A (es) |
| ES (1) | ES8200560A1 (es) |
| FI (1) | FI70721C (es) |
| FR (1) | FR2462167B1 (es) |
| GB (1) | GB2055384B (es) |
| HK (1) | HK40384A (es) |
| HU (1) | HU185382B (es) |
| IE (1) | IE50075B1 (es) |
| IL (1) | IL60697A (es) |
| IT (1) | IT1132269B (es) |
| KE (1) | KE3364A (es) |
| LU (1) | LU82673A1 (es) |
| MC (1) | MC1337A1 (es) |
| MY (1) | MY8500274A (es) |
| NL (1) | NL8004361A (es) |
| NO (1) | NO151158C (es) |
| NZ (1) | NZ194495A (es) |
| PH (2) | PH17738A (es) |
| PT (1) | PT71625B (es) |
| RO (1) | RO81474B (es) |
| SE (1) | SE466290B (es) |
| YU (1) | YU193480A (es) |
| ZA (1) | ZA803943B (es) |
| ZW (1) | ZW17980A1 (es) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI88175C (fi) | 1980-04-03 | 1993-04-13 | Biogen Inc | Rekombinant-dna-molekyler och foerfaranden foer framstaellning av polypeptider liknande humant -interferon |
| IL63916A0 (en) * | 1980-09-25 | 1981-12-31 | Genentech Inc | Microbial production of human fibroblast interferon |
| ZA83768B (en) * | 1982-03-01 | 1983-10-26 | Hoffmann La Roche | Homogeneous human immune interferon and process therefor |
| US4966843A (en) * | 1982-11-01 | 1990-10-30 | Cetus Corporation | Expression of interferon genes in Chinese hamster ovary cells |
| US4569790A (en) * | 1984-03-28 | 1986-02-11 | Cetus Corporation | Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions |
| US4530787A (en) * | 1984-03-28 | 1985-07-23 | Cetus Corporation | Controlled oxidation of microbially produced cysteine-containing proteins |
| US4894330A (en) * | 1986-12-23 | 1990-01-16 | Cetus Corporation | Purification of recombinant beta-interferon incorporating RP-HPLC |
| US6346510B1 (en) | 1995-10-23 | 2002-02-12 | The Children's Medical Center Corporation | Therapeutic antiangiogenic endostatin compositions |
| US20050002902A1 (en) * | 1995-12-28 | 2005-01-06 | Liming Yu | Hybrid with interferon-alpha and an immunoglobulin Fc for treatment of tumors and viral infections |
| US5723125A (en) * | 1995-12-28 | 1998-03-03 | Tanox Biosystems, Inc. | Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide |
| US20030026779A1 (en) * | 1999-10-15 | 2003-02-06 | Liming Yu | Treatment of tumors and viral infections with a hybrid conjugate of interferon and an immunoglobulin Fc |
| RS57549B1 (sr) | 2005-08-26 | 2018-10-31 | Ares Trading Sa | Proces za pripremu glikoziliranog interferona beta |
| CA2625978A1 (en) | 2005-12-09 | 2007-06-14 | Ares Trading S.A. | Method for purifying fsh or a fsh mutant |
| CA2702448A1 (en) * | 2007-10-22 | 2009-04-30 | Merck Serono S.A. | Method for purifying fc-fusion proteins |
| DE102009032179A1 (de) | 2009-07-07 | 2011-01-13 | Biogenerix Ag | Verfahren zur Reinigung von Interferon beta |
-
1980
- 1980-07-01 CH CH5082/80A patent/CH648331A5/de not_active IP Right Cessation
- 1980-07-01 ZA ZA00803943A patent/ZA803943B/xx unknown
- 1980-07-23 FR FR8016227A patent/FR2462167B1/fr not_active Expired
- 1980-07-29 IL IL60697A patent/IL60697A/xx unknown
- 1980-07-29 NZ NZ194495A patent/NZ194495A/en unknown
- 1980-07-29 MC MC801460A patent/MC1337A1/xx unknown
- 1980-07-29 HU HU801891A patent/HU185382B/hu unknown
- 1980-07-29 CA CA000357224A patent/CA1146468A/en not_active Expired
- 1980-07-29 PH PH24361A patent/PH17738A/en unknown
- 1980-07-30 ZW ZW179/80A patent/ZW17980A1/xx unknown
- 1980-07-30 PT PT71625A patent/PT71625B/pt unknown
- 1980-07-30 NO NO802297A patent/NO151158C/no unknown
- 1980-07-30 NL NL8004361A patent/NL8004361A/nl not_active Application Discontinuation
- 1980-07-30 DK DK328880A patent/DK159825C/da not_active IP Right Cessation
- 1980-07-30 AT AT0395080A patent/AT372387B/de not_active IP Right Cessation
- 1980-07-30 RO RO101841A patent/RO81474B/ro unknown
- 1980-07-30 IT IT23801/80A patent/IT1132269B/it active
- 1980-07-30 ES ES493849A patent/ES8200560A1/es not_active Expired
- 1980-07-30 DE DE19803028919 patent/DE3028919A1/de active Granted
- 1980-07-30 GB GB8024889A patent/GB2055384B/en not_active Expired
- 1980-07-30 IE IE1589/80A patent/IE50075B1/en unknown
- 1980-07-30 LU LU82673A patent/LU82673A1/de unknown
- 1980-07-30 AU AU60914/80A patent/AU536274B2/en not_active Expired
- 1980-07-31 SE SE8005498A patent/SE466290B/sv not_active IP Right Cessation
- 1980-07-31 FI FI802400A patent/FI70721C/fi not_active IP Right Cessation
- 1980-07-31 AR AR282016A patent/AR229931A1/es active
- 1980-07-31 YU YU01934/80A patent/YU193480A/xx unknown
- 1980-08-01 DO DO1980002948A patent/DOP1980002948A/es unknown
-
1983
- 1983-10-21 PH PH29729A patent/PH18479A/en unknown
-
1984
- 1984-01-11 KE KE3364A patent/KE3364A/xx unknown
- 1984-05-10 HK HK403/84A patent/HK40384A/xx not_active IP Right Cessation
-
1985
- 1985-12-30 MY MY274/85A patent/MY8500274A/xx unknown
-
1989
- 1989-07-14 US US07/386,088 patent/US5015730A/en not_active Expired - Lifetime
- 1989-10-05 JP JP1258989A patent/JPH02138226A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR229931A1 (es) | Procedimiento para producir interferon de fibroblasto humano esencialmente purificado como proteina homogenea | |
| ES490697A0 (es) | Un metodo de producir proteinas de interferon humano de for-ma le | |
| NZ192991A (en) | Preparation of purified protein hydrolysate | |
| DK478786D0 (da) | Cystein-forarmede muteiner af biologisk aktive humantumornekrosefaktorproteiner | |
| FR2490675B1 (fr) | Production microbienne d'interferon de fibroplaste humain | |
| BR8505074A (pt) | Mascara de respiracao descartavel | |
| IT1127253B (it) | Proteine purificate e procedimento per la loro preparazione | |
| NO149646C (no) | Engangsbleie | |
| ES491432A0 (es) | Procedimiento para obtener agentes de tratamiento de fibras queratinicas | |
| DK154045C (da) | Engangsble | |
| SE7800843L (sv) | Till polyamid fixerat biologiskt aktivt protein och forfarande for dess framstellning | |
| BR8003841A (pt) | Quadro de comutacao encoberto | |
| AR227021A1 (es) | Procedimiento de preparacion de concentrados de complejo protrombinico altamente purificado | |
| ES535509A0 (es) | Procedimiento para purificar interferon de humano | |
| IT1036478B (it) | Procedimento ed impianto per la fabricazione di libri cuciti | |
| SE7805026L (sv) | Aminohartskomposition i formfibrer | |
| BR8007022A (pt) | Fralda descartavel | |
| DK31386D0 (da) | Behandling af proliferative hudsygdomme | |
| ES543524A0 (es) | Procedimiento para preparar benzoxazolil- y benzotiazolil- aminoacidos | |
| AR229097A1 (es) | Imidas de acidos succinicos y procedimiento para prepararlas | |
| MX5066E (es) | Procedimiento mejorado para la elaboracion de piridina y 3-metilpiridina | |
| MX5672E (es) | Procedimiento para la preparacion de acidos 2-piridil y 2-pirimidil-aminobenzoicos | |
| IT1098014B (it) | Separazione di aminoacidi in antipodi ottici | |
| DK41585D0 (da) | Udtrykkelse af human alfa-1-antitrypsin i gaer | |
| IT1192563B (it) | Composizione per il trattamento di malattie allergiche |